524 results on '"Sattler, Martin"'
Search Results
2. Dual therapeutic targeting of MYC and JUNB transcriptional programs for enhanced anti-myeloma activity
3. Exploring the accessibility of primary health care data in Europe's COVID-19 response: developing key indicators for managing future pandemics (Eurodata study)
4. Spatial iTME analysis of KRAS mutant NSCLC and immunotherapy outcome
5. Correction: Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications
6. Formação (Bildung): entre o sagrado e o profano = Education (Bildung): between the sacred and the profane
7. Phenotypic Switching of Naïve T Cells to Immune-Suppressive Treg-Like Cells by Mutant KRAS.
8. EPHA2 mutations with oncogenic characteristics in squamous cell lung cancer and malignant pleural mesothelioma.
9. The Role of Surgery in Pleural Mesothelioma
10. BRD9 degraders as chemosensitizers in acute leukemia and multiple myeloma
11. Essential role of the histone lysine demethylase KDM4A in the biology of malignant pleural mesothelioma (MPM)
12. The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC)
13. Primary care indicators for disease burden, monitoring and surveillance of COVID-19 in 31 European countries: Eurodata Study
14. Synergy between BRD9- and IKZF3-Targeting as a Therapeutic Strategy for Multiple Myeloma
15. Primary care indicators for disease burden, monitoring and surveillance of COVID-19 in 31 European countries: Eurodata Study
16. Inhibition of the deubiquitinase USP10 induces degradation of SYK
17. General practitioners’ deprescribing decisions in older adults with polypharmacy: a case vignette study in 31 countries
18. Chimeric Antigen Receptor T Cell Therapy in Acute Myeloid Leukemia: Trials and Tribulations
19. Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer
20. Patient Characteristics and General Practitioners’ Advice to Stop Statins in Oldest-Old Patients: a Survey Study Across 30 Countries
21. Critical role for Gab2 in transformation by BCR/ABL.
22. Abstract 6248: Inhibiting β-catenin in AML by targeting DDX5
23. A Closer Look at EGFR Inhibitor Resistance in Non-Small Cell Lung Cancer through the Lens of Precision Medicine
24. LSD1-targeted therapy—a multi-purpose key to unlock immunotherapy in small cell lung cancer
25. The role of primary health care in long-term care facilities during the COVID-19 pandemic in 30 European countries: a retrospective descriptive study (Eurodata study)
26. Identification of novel therapeutic targets in acute leukemias with NRAS mutations using a pharmacologic approach
27. Clinical and Molecular Features of KRAS-Mutated Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
28. Effect of tree shelters on the survival and growth of coniferous tree species in Central South Bulgaria
29. Effect of tree shelters on the survival and growth of coniferous tree species in Central South Bulgaria
30. Rac2-MRC-cIII–generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors
31. YAP1 maintains active chromatin state in head and neck squamous cell carcinomas that promotes tumorigenesis through cooperation with BRD4
32. Correction: Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung Cancer
33. EFFECT OF TREE SHELTERS ON THE SURVIVAL AND GROWTH OF DECIDUOUS TREE SPECIES IN NORTH-WESTERN BULGARIA
34. Functional Screening Identifies CRLF2 in Precursor B-Cell Acute Lymphoblastic Leukemia
35. Novel Therapeutic Targets and Immune Dysfunction in Malignant Pleural Mesothelioma
36. The Small-Molecule VEGF Receptor Inhibitor Pazopanib (GW786034B) Targets Both Tumor and Endothelial Cells in Multiple Myeloma
37. Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers
38. Combined Targeting of Distinct c-Myc and JunB Transcriptional Programs Inducing Synergistic Anti-Myeloma Activity
39. Biomechanical Performance of BoneHelix® Compared with Elastic Stable Intramedullary Nailing (ESIN) in a Pediatric Tibia Fracture Model
40. Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications
41. BCR-ABL promotes the frequency of mutagenic single-strand annealing DNA repair
42. Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung Cancer
43. a case vignette study in 31 countries
44. The Jak2V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim proto-oncogenes
45. Co-stimulatory and co-inhibitory immune markers in solid tumors with MET alterations
46. Superoxide-dependent and -independent mitochondrial signaling during apoptosis in multiple myeloma cells
47. Differential expression and signaling of CBL and CBL-B in BCR/ABL transformed cells
48. Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571
49. Expression of the focal adhesion protein paxillin in lung cancer and its relation to cell motility
50. Inhibitors of the Transcription Factor STAT3 Decrease Growth and Induce Immune Response Genes in Models of Malignant Pleural Mesothelioma (MPM)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.